Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study

Liver Transplantation

Volumn 7, Issue 10, 2001, Pages 870-876

  Alberti, Alberto Battista ^a,b,c,d   Belli, Luca Saverio ^a,b,c,d   Airoldi, Aldo ^a,b,c,d   De Carlis, Luciano ^a,b,c,d   Rondinara, Gianfranco ^a,b,c,d   Minola, Ernesto ^a,b,c,d   Vangeli, Marcello ^a,b,c,d   Cernuschi, Alessandra ^a,b,c,d   D'Amico, Maria ^a,b,c,d   Forti, Domenico ^a,b,c,d   Pinzello, Giovambattista ^a,b,c,d  

^a Center for Liver Diseases   (Italy)

^b Transplant Unit   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; IRON; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; THYMOCYTE ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLEARANCE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; FOLLOW UP; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IRON STORAGE; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MONOTHERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT INFECTION; SCORING SYSTEM; SERUM;

EID: 0034764295     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.27871     Document Type: Article

References (20)

1. Liver transplantation for chronic hepatitis C viral infection
2. Long-term outcome of hepatitis C infection after liver transplantation
3. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C
4. Long term outcome of hepatitis C virus infection after liver transplantation
5. HCV-related fibrosis progression following liver transplantation: Increase in recent years
6. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
7. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
8. Histologic grading and staging of chronic hepatitis
9. Typing hepatitis C virus by polymerase chain reaction with type specific primers: Application to clinical surveys and tracing infectious sources
10. Variability of hepatitis C virus
11. Detection of hepatitis C by RT-PCR in formalin-fixed and paraffin-embedded tissue from liver transplant patients
12. Long-term follow-up study of sustained biochemical responders with interferon therapy
13. Interferon alfa for hepatitis C virus infection following liver transplantation
14. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection
15. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation
16. A longitudinal analysis of hepatitis C virus replication following liver transplantation
17. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation
18. Long term efficacy of ribavirin plus IFN in the treatment of HCV recurrence after liver transplantation
19. Treatment of recurrent hepatitis C virus infection after liver transplantation
20. Conquering hepatitis C, step by step